Company Filing History:
Years Active: 2012-2013
Title: Guo Hongli: Innovator in Isoquinolinium Compounds
Introduction
Guo Hongli is a notable inventor based in Shanghai, China. He has made significant contributions to the field of chemistry, particularly in the development of isoquinolinium compounds. With a total of 2 patents, his work has implications for the pharmaceutical industry.
Latest Patents
Guo's latest patents include innovative methods related to isoquinolinium compounds. One of his patents focuses on "Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates." This invention provides novel isoquinolinium compounds and methods for producing them, which can be converted into cisatracurium, specifically cisatracurium besylate. The isoquinolinium compounds can be obtained in solid form and purified using simple techniques, allowing for the production of pure cisatracurium besylate without the need for HPLC purification. Another patent details the "Process for producing cisatracurium compounds and associated intermediates," which outlines processes for creating isoquinolinium compounds and converting them into cisatracurium salts.
Career Highlights
Guo Hongli is associated with Chemagis Ltd., where he continues to innovate in his field. His work has garnered attention for its practical applications in drug development and synthesis.
Collaborations
Guo has collaborated with notable colleagues, including Vladimir Naddaka and Shen Jingshan, contributing to a dynamic research environment.
Conclusion
Guo Hongli's contributions to the field of isoquinolinium compounds highlight his innovative spirit and dedication to advancing pharmaceutical chemistry. His patents reflect a commitment to improving drug synthesis processes, making a significant impact in the industry.